Cytochrome P450 (P450) 2A6 is an important human enzyme involved in the metabolism of many xenobiotic chemicals including coumarin, indole, nicotine, and carcinogenic nitrosamines. A combination of random mutagenesis and high-throughput screening was used in the analysis of P450 2A6, utilizing a fluorescent coumarin 7-hydroxylation assay. The steady-state kinetic parameters (k cat and K m ) for coumarin 7-hydroxylation by wild-type P450 2A6 and 35 selected mutants were measured and indicated that mutants throughout the coding region can have effects on activity. Five mutants showing decreased catalytic efficiency (k cat /K m ) were further analyzed for substrate selectivity and binding affinities and showed reduced catalytic activities for 7-methoxycoumarin O-demethylation, tert-butyl methyl ether O-demethylation, and indole 3-hydroxylation. All mutants except one (K476E) showed decreased coumarin binding affinities (and also higher K m values), indicating that this is a major basis for the decreased enzymatic activities. A recent x-ray crystal structure of P450 2A6 bound to coumarin (Yano, J. K., Hsu, M. H., Griffin, K. J., Stout, C. D., and Johnson, E. F. (2005) Nat. Struct. Mol. Biol. 12, 822-823) indicates that the recovered A481T and N297S mutations appear to be close to coumarin, suggesting direct perturbation of substrate interaction. The decreased enzymatic activity of the K476E mutant was associated with decreases both in NADPH oxidation and the reduction rate of the ferric P450 2A6-coumarin complex. The attenuation is caused in part to lower binding affinity for NADPH-P450 reductase, but the K476E mutant did not achieve the wild-type coumarin 7-hydroxylation activity even at high reductase concentrations.
Cytochrome P4502 enzymes are the major catalysts involved in the oxidative metabolism of xenobiotic chemicals, a significant focus in the areas of toxicology, drug metabolism, and pharmacology (3-5). Human P450 2A6 was identified as the major coumarin 7-hydroxlylase in humans (6 -8), and this enzyme also plays an important role in the metabolism of many xenobiotics including coumarin, nicotine, and tobacco-specific nitrosamines (8 -12). Genetic polymorphisms have been identified, and their relevance to cancer risk has been proposed because of the variations in nicotine and N-nitrosamine metabolism (13-17). The oxidation of indoles by P450 2A6 has been characterized, and the new kinase inhibitors have been biosynthesized using P450 2A6 mutants (18 -22).Recently x-ray crystal structures have been reported for P450 2A6 bound with coumarin and methoxsalen (23). The active site of P450 2A6 is six times smaller than that of human P450 2C8 (23, 24), even smaller than that of bacterial P450 101A1 (25). The decrease in size of the active site in P450 2A6 relative to P450 2C8 is caused by repositioning of helix BЈ and helices F to H toward the active site. Large aromatic residues in the active site of P450 2A6 also reduce the volume of the substrate binding site.In recent years, random mutagenesis and high-thro...